BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12892251)

  • 1. Profiles of the acute-phase reactants C-reactive protein and ferritin related to the disease course of patients with systemic lupus erythematosus.
    Hesselink DA; Aarden LA; Swaak AJ
    Scand J Rheumatol; 2003; 32(3):151-5. PubMed ID: 12892251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between serum ferritin levels and disease activity in systemic lupus erythematosus.
    Beyan E; Beyan C; Demirezer A; Ertuğrul E; Uzuner A
    Scand J Rheumatol; 2003; 32(4):225-8. PubMed ID: 14626629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ferritin as a serologic marker of activity in systemic lupus erythematosus.
    Lim MK; Lee CK; Ju YS; Cho YS; Lee MS; Yoo B; Moon HB
    Rheumatol Int; 2001 Apr; 20(3):89-93. PubMed ID: 11354563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of serum ferritin levels as a marker for active systemic lupus erythematosus.
    Nishiya K; Hashimoto K
    Clin Exp Rheumatol; 1997; 15(1):39-44. PubMed ID: 9093771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
    Tripathy R; Panda AK; Das BK
    Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
    Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
    Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Serum Ferritin Levels with Hematological Manifestations in Systemic Lupus Erythematosus Patients from Western India.
    Pradhan V; Pandit P; Rajadhyaksha A; Patwardhan M; Surve P; Kamble P; Lecerf M; Bayry J; Kaveri S; Ghosh K; Nadkar MY
    J Assoc Physicians India; 2016 May; 64(5):14-18. PubMed ID: 27735143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between anti-C-reactive protein and disease activity in patients with systemic lupus erythematosus.
    Son CN; Lee TH; Bang JH; Jeong HJ; Chae JN; Lee WM; Kim JM; Kim SH
    Korean J Intern Med; 2018 Jul; 33(4):823-828. PubMed ID: 28352058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus.
    Chung CP; Ormseth MJ; Connelly MA; Oeser A; Solus JF; Otvos JD; Raggi P; Stein CM
    Lupus; 2016 Mar; 25(3):296-300. PubMed ID: 26637290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do high sensitivity C-reactive protein and serum interleukin-6 levels correlate with disease activity in systemic lupus erythematosuspatients?
    Umare V; Nadkarni A; Nadkar M; Rajadhyksha A; Khadilkar P; Ghosh K; Pradhan VD
    J Postgrad Med; 2017; 63(2):92-95. PubMed ID: 27531690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus.
    Sjöwall C; Bengtsson AA; Sturfelt G; Skogh T
    Arthritis Res Ther; 2004; 6(2):R87-94. PubMed ID: 15059271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein +1444CT (rs1130864) genetic polymorphism is associated with the susceptibility to systemic lupus erythematosus and C-reactive protein levels.
    Delongui F; Lozovoy MAB; Iriyoda TMV; Costa NT; Stadtlober NP; Alfieri DF; Flauzino T; Dichi I; Simão ANC; Reiche EMV
    Clin Rheumatol; 2017 Aug; 36(8):1779-1788. PubMed ID: 28567557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there still a place for erythrocyte sedimentation rate and C-reactive protein in systemic lupus erythematosus?
    Dima A; Opris D; Jurcut C; Baicus C
    Lupus; 2016 Oct; 25(11):1173-9. PubMed ID: 27256317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
    Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk.
    Barnes EV; Narain S; Naranjo A; Shuster J; Segal MS; Sobel ES; Armstrong AE; Santiago BE; Reeves WH; Richards HB
    Lupus; 2005; 14(8):576-82. PubMed ID: 16175928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
    Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
    PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ratio of erythrocyte sedimentation rate to C-reactive protein is useful in distinguishing infection from flare in systemic lupus erythematosus patients presenting with fever.
    Littlejohn E; Marder W; Lewis E; Francis S; Jackish J; McCune WJ; Somers EC
    Lupus; 2018 Jun; 27(7):1123-1129. PubMed ID: 29546774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin impact on disease activity and C-reactive protein concentrations in systemic lupus erythematosus patients: A systematic review and meta-analysis of controlled trials.
    Sahebkar A; Rathouska J; Derosa G; Maffioli P; Nachtigal P
    Autoimmun Rev; 2016 Apr; 15(4):344-53. PubMed ID: 26747436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-operative and post-operative changes in CRP and other biomarkers sensitive to inflammatory status in patients with severe obesity undergoing laparoscopic sleeve gastrectomy.
    Randell EW; Twells LK; Gregory DM; Lester KK; Daneshtalab N; Dillon C; Pace D; Smith C; Boone D
    Clin Biochem; 2018 Feb; 52():13-19. PubMed ID: 29051034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin.
    González AS; Guerrero DB; Soto MB; Díaz SP; Martinez-Olmos M; Vidal O
    Eur J Clin Nutr; 2006 Jun; 60(6):802-9. PubMed ID: 16493453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.